Study Cites High Cancer Rates Among African-Americans

Publication
Article
OncologyONCOLOGY Vol 20 No 11
Volume 20
Issue 11

Astudy conducted by researchers from the Medical University of South Carolina (MUSC) and University of South Carolina shows that the cancer rate among blacks living in South Carolina is nearly twice as great as it is for whites in the state.

Astudy conducted by researchers from the Medical University of South Carolina (MUSC) and University of South Carolina shows that the cancer rate among blacks living in South Carolina is nearly twice as great as it is for whites in the state. The study, released September 13 by the Journal of the South Carolina Medical Association, focuses on racial imbalances that exist in African-American and European-American cancer rates in South Carolina, while comparing cancer disparities between the two races nationally.

Key Findings

South Carolina leads the nation in cancer rates. The study found that in South Carolina:

• African-American women are about 60% more likely than white women to die from breast cancer after diagnosis, which is the largest disparity in the country.

• African-American men are nearly 80% more likely to get prostate cancer and nearly three times more likely to die of the disease than white men. This is about 50% of the rate nationally.

• Both African-American men and women are more likely to have and die of colorectal cancer than their white counterparts.

• African-American women are much more likely to be diagnosed and die from cervical cancer; despite similar screening rates.

Innovative Programs

MUSC's Anthony Alberg, PhD, associate director and chairman of Cancer Prevention and Control at MUSC's Hollings Cancer Center, the largest academic-based cancer program in South Carolina, also was an author of the study. His focus has been on the causes of lung cancer among African-Americans.

"We understand the importance of the issue of cancer disparities, and we are creating innovative programs to help educate African-Americans on the importance of early tests, and how lifestyle choices, including not smoking, eating a healthy diet, and exercise can help to prevent many cancers," said Dr. Alberg.

Meanwhile, programs including Health-e-AME and Brothers Against Prostate Cancer, which is operated through barber shops in South Carolina, are supported by MUSC and focus on cancer prevention and other health disparities among African-Americans.

Although some of the differences are clearly related to socioeconomic factors that determine access to health care, "we are pretty much in the dark regarding many of the underlying causes," said James Hebert, PhD, a University of South Carolina researcher and a journal contributor.

Recent Videos
Performance status, age, and comorbidities may impact benefit seen with immunotherapy vs chemotherapy in patients with breast cancer.
Updated results from the 1b/2 ELEVATE study elucidate synergizing effects observed with elacestrant plus targeted therapies in ER+/HER2– breast cancer.
Patients with ESR1+, ER+/HER2– breast cancer resistant to chemotherapy may benefit from combination therapy with elacestrant.
Ablative technology may generate an immune response that can be enhanced via injected immunotherapy in patients with solid tumors.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Related Content